Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon

Diseases of the Colon and Rectum

Volumn 62, Issue 2, 2019, Pages 181-188

  Skancke, Matthew ^a   Arnott, Suzanne M ^a   Amdur, Richard L ^a   Siegel, Robert S ^a   Obias, Vincent J ^a   Umapathi, Bindu A ^a  

^a GEORGE WASHINGTON UNIVERSITY HOSPITAL   (United States)

Author keywords

Adenocarcinoma; Chemotherapy; Lymphovascular invasion; Perineural invasion

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; AGED; ARTICLE; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHARLSON COMORBIDITY INDEX; COLON ADENOCARCINOMA; FEMALE; HUMAN; HUMAN TISSUE; LYMPH VESSEL METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERINEURAL INVASION; RETROSPECTIVE STUDY; ADENOCARCINOMA; COLON TUMOR; KAPLAN MEIER METHOD; LYMPH VESSEL; MORTALITY; PATHOLOGY; PERIPHERAL NERVE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; TUMOR INVASION;

ADENOCARCINOMA; AGED; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC VESSELS; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERIPHERAL NERVES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 85060005740     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0000000000001258     Document Type: Article

References (27)

1. Siegel RL, Miller KD, Fedewa SA, et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67:177-193.
2. Schrag D, Rifas-Shiman S, Saltz L, Bach PB, Begg CB. Adjuvant chemotherapy use for Medicare beneficiaries with stage II colon cancer. J Clin Oncol. 2002;20:3999-4005.
3. Shah MA, Renfro LA, Allegra CJ, et al. Impact of patient factors on recurrence risk and time dependency of oxaliplatin benefit in patients with colon cancer: Analysis from modernera adjuvant studies in the Adjuvant Colon Cancer End Points (ACCENT) database. J Clin Oncol. 2016;34:843-853.
4. Schippinger W, Samonigg H, Schaberl-Moser R, et al.; Austrian Breast and Colorectal Cancer Study Group. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Br J Cancer. 2007;97:1021-1027.
5. Böckelman C, Engelmann BE, Kaprio T, Hansen TF, Glimelius B. Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature. Acta Oncol. 2015;54:5-16.
6. André T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol. 2009;27:3109-3116.
7. Casadaban L, Rauscher G, Aklilu M, Villenes D, Freels S, Maker AV. Adjuvant chemotherapy is associated with improved survival in patients with stage II colon cancer. Cancer. 2016;122:3277-3287.
8. Yun HR, Kim HC, Lee WY, Cho YB, Yun SH, Chun HK. The necessity of chemotherapy in T3N0M0 colon cancer without risk factors. Am J Surg. 2009;198:354-358.
9. Yun HR, Kim HC, Yun SH, Lee WY. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer. Hepatogastroenterology. 2012;59:2466-2471.
10. McKenzie S, Nelson R, Mailey B, et al. Adjuvant chemotherapy improves survival in patients with American Joint Committee on Cancer stage II colon cancer. Cancer. 2011;117:5493-5499.
11. Lin CC, Lin JK, Chang SC, et al. Is adjuvant chemotherapy beneficial to high risk stage II colon cancer Analysis in a single institute. Int J Colorectal Dis. 2009;24:665-676.
12. Nikberg M, Chabok A, Letocha H, Kindler C, Glimelius B, Smedh K. Lymphovascular and perineural invasion in stage II rectal cancer: A report from the Swedish colorectal cancer registry. Acta Oncol. 2016;55:1418-1424.
13. Fujita S, Nakanisi Y, Taniguchi H, et al. Cancer invasion to Auerbach's plexus is an important prognostic factor in patients with pT3-pT4 colorectal cancer. Dis Colon Rectum. 2007;50:1860-1866.
14. Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID. Perineural invasion is a strong prognostic factor in colorectal cancer: A systematic review. Am J Surg Pathol. 2016;40:103-112.
15. Huh JW, Kim HR, Kim YJ. Prognostic value of perineural invasion in patients with stage II colorectal cancer. Ann Surg Oncol. 2010;17:2066-2072.
16. Liebig C, Ayala G, Wilks J, et al. Perineural invasion is an independent predictor of outcome in colorectal cancer. J Clin Oncol. 2009;27:5131-5137.
17. Yang Y, Huang X, Sun J, et al. Prognostic value of perineural invasion in colorectal cancer: A meta-analysis. J Gastrointest Surg. 2015;19:1113-1122.
18. Cienfuegos JA, Martínez P, Baixauli J, et al. Perineural invasion is a major prognostic and predictive factor of response to adju vant chemotherapy in stage I-II colon cancer. Ann Surg Oncol. 2017;24:1077-1084.
19. Levin B, Lieberman DA, McFarland B, et al.; American Cancer Society Colorectal Cancer Advisory Group; US Multi-Society Task Force; American College of Radiology Colon Cancer Committee. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, the American College of Radiology. CA Cancer J Clin. 2008;58:130-160.
20. O'Connor ES, Greenblatt DY, LoConte NK, et al. Adjuvant chemotherapy for stage II colon cancer with poor prognostic features. J Clin Oncol. 2011;29:3381-3388.
21. Lin HH, Chang YY, Lin JK, et al. The role of adjuvant chemotherapy in stage II colorectal cancer patients. Int J Colorectal Dis. 2014;29:1237-1243.
22. Minsky BD, Mies C, Rich TA, Recht A. Lymphatic vessel invasion is an independent prognostic factor for survival in colorectal cancer. Int J Radiat Oncol Biol Phys. 1989;17:311-318.
23. Batsakis JG. Nerves and neurotropic carcinomas. Ann Otol Rhinol Laryngol. 1985;94(4 pt 1):426-427.
24. Compton C, Fenoglio-Preiser CM, Pettigrew N, Fielding LP. American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer. 2000;88:1739-1757.
25. Al-Sukhni E, Attwood K, Gabriel EM, LeVea CM, Kanehira K, Nurkin SJ. Lymphovascular and perineural invasion are associated with poor prognostic features and outcomes in colorectal cancer: A retrospective cohort study. Int J Surg. 2017;37:42-49.
26. Ejaz A, Casadaban L, Maker AV. Utilization and impact of adjuvant chemotherapy among patients with resected stage II colon cancer: A multi-institutional analysis. J Surg Res. 2017;215:12-20.
27. Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ; Quasar Collaborative Group. Adjuvant chemotherapy versus observation in patients with colorectal cancer: A randomised study. Lancet. 2007;370:2020-2029. New